Published in Mol Vis on April 26, 2012
Interactions of indocyanine green and lipid in enhancing near-infrared fluorescence properties: the basis for near-infrared imaging in vivo. Biochemistry (2014) 0.83
Expression of pigment epithelium-derived factor and thrombospondin-1 regulate proliferation and migration of retinal pigment epithelial cells. Physiol Rep (2015) 0.81
Ranibizumab and bevacizumab for neovascular age-related macular degeneration. N Engl J Med (2011) 19.42
Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol (2004) 18.86
An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol (2007) 8.12
The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology (1997) 6.47
Randomized, double-masked, sham-controlled trial of ranibizumab for neovascular age-related macular degeneration: PIER Study year 1. Am J Ophthalmol (2008) 5.22
Age-related macular degeneration. N Engl J Med (2006) 5.06
Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol (1998) 2.33
Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J Clin Invest (1998) 1.72
Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol (1997) 1.65
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer (2003) 1.38
Organ-specific endothelial cell uptake of cationic liposome-DNA complexes in mice. Am J Physiol (1997) 1.25
Enhanced efficacy associated with early treatment of neovascular age-related macular degeneration with pegaptanib sodium: an exploratory analysis. Retina (2005) 1.23
Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin Cancer Res (2003) 1.18
Fate of cationic liposomes and their complex with oligonucleotide in vivo. Biochim Biophys Acta (1996) 1.10
Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. Int J Cancer (2004) 0.97
Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis. Ann Oncol (2011) 0.97
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J Invest Dermatol (2003) 0.95
Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Exp Eye Res (2008) 0.94
Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes. Int J Cancer (2008) 0.92
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. Int J Cancer (2010) 0.89
Physicochemical and disposition characteristics of antisense oligonucleotides complexed with glycosylated poly(L-lysine). Biochem Pharmacol (1997) 0.87
Visualization of the retinal and choroidal microvasculature by fluorescent liposomes. Methods Enzymol (2003) 0.86
Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer. Oncol Rep (2009) 0.84
Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats. Inflamm Res (2010) 0.82
Fluorescent vesicle angiography with sodium fluorescein and indocyanine green. Ophthalmic Surg Lasers (1996) 0.78
Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study. Diabetes Care (2010) 3.29
Intravitreal bevacizumab (Avastin) versus ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a safety review. Br J Ophthalmol (2010) 1.67
Retinal endovascular lysis in ischemic central retinal vein occlusion: one-year results of a pilot study. Ophthalmology (2006) 1.52
Successful treatment of cystoid macular edema with valdecoxib. J Cataract Refract Surg (2007) 1.50
Guanylate-binding protein-1 expression is selectively induced by inflammatory cytokines and is an activation marker of endothelial cells during inflammatory diseases. Am J Pathol (2002) 1.42
Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels. Int J Cancer (2003) 1.38
Light emitting diode microscope illumination for green fluorescent protein or fluorescein isothiocyanate epifluorescence. Biotechniques (2005) 1.29
Interactions between sterol biosynthesis genes in embryonic development of Arabidopsis. Plant J (2002) 1.27
Valproic acid-mediated neuroprotection and regeneration in injured retinal ganglion cells. Invest Ophthalmol Vis Sci (2009) 1.24
Bevacizumab in retinal vein occlusion-results of a prospective case series. Graefes Arch Clin Exp Ophthalmol (2007) 1.22
VEGF-A165b is cytoprotective and antiangiogenic in the retina. Invest Ophthalmol Vis Sci (2010) 1.20
Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy. Clin Cancer Res (2003) 1.18
Intravitreal bevacizumab (Avastin) vs. ranibizumab (Lucentis) for the treatment of age-related macular degeneration: a systematic review. Curr Opin Ophthalmol (2010) 1.16
Development of AAVLP(HPV16/31L2) particles as broadly protective HPV vaccine candidate. PLoS One (2012) 1.08
Nuclear factor-kappaB motif and interferon-alpha-stimulated response element co-operate in the activation of guanylate-binding protein-1 expression by inflammatory cytokines in endothelial cells. Biochem J (2004) 1.05
Ca2+ channels in retinal pigment epithelial cells regulate vascular endothelial growth factor secretion rates in health and disease. Mol Vis (2007) 1.04
EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX. Blood (2004) 1.01
Cultivation of retinal pigment epithelial cells from human choroidal neovascular membranes in age related macular degeneration. Exp Eye Res (2002) 0.98
Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature. Int J Cancer (2004) 0.97
Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J Invest Dermatol (2003) 0.95
Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin. Clin Cancer Res (2008) 0.94
Levels of VEGF but not VEGF(165b) are increased in the vitreous of patients with retinal vein occlusion. Am J Ophthalmol (2011) 0.94
Semaphorin 3F forms an anti-angiogenic barrier in outer retina. FEBS Lett (2013) 0.94
Combinatory inhibition of VEGF and FGF2 is superior to solitary VEGF inhibition in an in vitro model of RPE-induced angiogenesis. Graefes Arch Clin Exp Ophthalmol (2009) 0.94
Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes. Int J Cancer (2008) 0.92
Intravitreal injection of the heparin analog 5-amino-2-naphthalenesulfonate reduces retinal neovascularization in mice. Exp Eye Res (2007) 0.92
Differential expression of angioregulatory factors in normal and CNV-derived human retinal pigment epithelium. Graefes Arch Clin Exp Ophthalmol (2004) 0.90
Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer. Int J Cancer (2010) 0.89
Vitreal levels of erythropoietin are increased in patients with retinal vein occlusion and correlate with vitreal VEGF and the extent of macular edema. Retina (2010) 0.89
Therapeutic interference with EphrinB2 signalling inhibits oxygen-induced angioproliferative retinopathy. Acta Ophthalmol (2011) 0.88
Enhanced TKTL1 expression in malignant tumors of the ocular adnexa predicts clinical outcome. Ophthalmology (2012) 0.87
Retinal vascular occlusions: an interdisciplinary challenge. Dtsch Arztebl Int (2008) 0.87
Bilateral serous retinal detachment. Br J Ophthalmol (2013) 0.86
Highly potent VEGF-A-antagonistic DARPins as anti-angiogenic agents for topical and intravitreal applications. Angiogenesis (2012) 0.86
Expression of p16 in conjunctival intraepithelial neoplasia does not correlate with HPV-infection. Open Ophthalmol J (2008) 0.85
Paclitaxel encapsulated in cationic liposomes: a new option for neovascular targeting for the treatment of prostate cancer. Oncol Rep (2009) 0.84
Annular fundus autofluorescence abnormality in a case of macular dystrophy. Doc Ophthalmol (2007) 0.84
Strains of JC virus in Amerind-speakers of North America (Salish) and South America (Guaraní), Na-Dene-speakers of New Mexico (Navajo), and modern Japanese suggest links through an ancestral Asian population. Am J Phys Anthropol (2002) 0.83
Bevacizumab in central retinal vein occlusion: a retrospective analysis after 2 years of treatment. Eur J Ophthalmol (2010) 0.83
Arterio-venous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a non-randomised prospective study. Graefes Arch Clin Exp Ophthalmol (2005) 0.83
Comparison of lung accumulation of cationic liposomes in normal rats and LPS-treated rats. Inflamm Res (2010) 0.82
Arteriovenous dissection in a living human eye: clinicopathologic correlation. Arch Ophthalmol (2005) 0.82
Activation of retinal microglia rather than microglial cell density correlates with retinal neovascularization in the mouse model of oxygen-induced retinopathy. J Neuroinflammation (2011) 0.82
Adeno-associated virus-like particles as new carriers for B-cell vaccines: testing immunogenicity and safety in BALB/c mice. Viral Immunol (2014) 0.81
Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndrome. Invest Ophthalmol Vis Sci (2008) 0.81
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in mice. Graefes Arch Clin Exp Ophthalmol (2005) 0.81
Plasma sE-selectin in premature infants: a possible surrogate marker of retinopathy of prematurity. Invest Ophthalmol Vis Sci (2010) 0.79
Hyperoxia causes reduced density of retinal astrocytes in the central avascular zone in the mouse model of oxygen-induced retinopathy. Mol Cell Neurosci (2013) 0.79
Antagonistic TNF receptor one-specific antibody (ATROSAB): receptor binding and in vitro bioactivity. PLoS One (2013) 0.79
A single local injection of recombinant VEGF receptor 2 but not of Tie2 inhibits retinal neovascularization in the mouse. Curr Eye Res (2005) 0.79
Histopathological findings after retinal endovascular lysis in central retinal vein occlusion. Br J Ophthalmol (2007) 0.78
Quantification of retrograde axonal transport in the rat optic nerve by fluorogold spectrometry. PLoS One (2012) 0.77
Phase I/II clinical study on safety and antivascular effects of paclitaxel encapsulated in cationic liposomes for targeted therapy in advanced head and neck cancer. Head Neck (2013) 0.77
JC virus genotypes in the western Pacific suggest Asian mainland relationships and virus association with early population movements. Hum Biol (2002) 0.77
Intra- and postoperative risks and complications of small-gauge (23-G) versus conventional (20-G) vitrectomy for macular surgery. Eur J Ophthalmol (2014) 0.77
Cyclooxygenase-2 inhibitors: a new therapeutic option in the treatment of macular edema after cataract surgery. J Cataract Refract Surg (2005) 0.77
Genotypes of JC virus, DNA of cytomegalovirus, and proviral DNA of human immunodeficiency virus in eyes of acquired immunodeficiency syndrome patients. J Neurovirol (2005) 0.76
Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Mol Vis (2004) 0.76
Histopathological findings after retinal endovascular lysis in central retinal vein occlusion. BMJ Case Rep (2009) 0.75
Cells of the vitreous body in Behçet's disease. A case report. Adv Exp Med Biol (2003) 0.75
Maternal HIV type 1 infection suppresses MMP-1 expression in endothelial cells of uninfected newborns: nonviral vertical transmission of HIV type 1-related effects. AIDS Res Hum Retroviruses (2005) 0.75
Expression of Angiogenic and Inflammatory Factors in Choroidal Neovascularisation-Derived Retinal Pigment Epithelium. Ophthalmic Res (2017) 0.75
[Laudatio to the 65th birthday of Heinrich Witschel]. Klin Monbl Augenheilkd (2002) 0.75
Phase I clinical study of vascular targeting fluorescent cationic liposomes in head and neck cancer. Eur Arch Otorhinolaryngol (2012) 0.75
Extraction and quantification of the cationic lipid 1,2-dioleoyl-3-trimethylammonium propane from human plasma. Anal Biochem (2007) 0.75
Reduction of vascular endothelial growth factor a in human breast milk after intravitreal injection of bevacizumab but not ranibizumab. Arch Ophthalmol (2012) 0.75